Please login to the form below

F2G

This page shows the latest F2G news and features for those working in and with pharma, biotech and healthcare.

AstraZeneca’s John Rex joins UK biotech F2G

John Rex has moved from AstraZeneca to F2G to become the Manchester, UK-based drug discovery firm's chief medical officer. ... new role Rex will be tasked with helping move F2G's first-in-class antifungal F901218 through phase II clinical trials.
F2G appoints chief financial officer

Ralf Schmid brings experience from Nabriva Therapeutics. Manchester-based F2G Ltd has appointed Ralf Schmid as its new chief financial officer. ... Ian Nicholson, chief executive of F2G, said: “Following our successful $60m financing, I am delighted to

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Add my company

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Working together against COVID-19: Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19: Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?: Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....